Pecfusituzumab

Jump to: navigation, search
Pecfusituzumab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Pecfusituzumab

Articles

Most recent articles on Pecfusituzumab

Most cited articles on Pecfusituzumab

Review articles on Pecfusituzumab

Articles on Pecfusituzumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pecfusituzumab

Images of Pecfusituzumab

Photos of Pecfusituzumab

Podcasts & MP3s on Pecfusituzumab

Videos on Pecfusituzumab

Evidence Based Medicine

Cochrane Collaboration on Pecfusituzumab

Bandolier on Pecfusituzumab

TRIP on Pecfusituzumab

Clinical Trials

Ongoing Trials on Pecfusituzumab at Clinical Trials.gov

Trial results on Pecfusituzumab

Clinical Trials on Pecfusituzumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pecfusituzumab

NICE Guidance on Pecfusituzumab

NHS PRODIGY Guidance

FDA on Pecfusituzumab

CDC on Pecfusituzumab

Books

Books on Pecfusituzumab

News

Pecfusituzumab in the news

Be alerted to news on Pecfusituzumab

News trends on Pecfusituzumab

Commentary

Blogs on Pecfusituzumab

Definitions

Definitions of Pecfusituzumab

Patient Resources / Community

Patient resources on Pecfusituzumab

Discussion groups on Pecfusituzumab

Patient Handouts on Pecfusituzumab

Directions to Hospitals Treating Pecfusituzumab

Risk calculators and risk factors for Pecfusituzumab

Healthcare Provider Resources

Symptoms of Pecfusituzumab

Causes & Risk Factors for Pecfusituzumab

Diagnostic studies for Pecfusituzumab

Treatment of Pecfusituzumab

Continuing Medical Education (CME)

CME Programs on Pecfusituzumab

International

Pecfusituzumab en Espanol

Pecfusituzumab en Francais

Business

Pecfusituzumab in the Marketplace

Patents on Pecfusituzumab

Experimental / Informatics

List of terms related to Pecfusituzumab


Overview

Pecfusituzumab is a humanized monoclonal antibody used to treat cancers of the epithelial origin. It binds to interleukin-2.



Linked-in.jpg